Dermatitis, atopic Trials in Granada, Spain
Conditions / Dermatitis, atopic / Granada, Spain
Dermatitis, atopic is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03992417 | Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | — |
| NCT06181435 | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06224348 | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids | COMPLETED | PHASE3 |
| NCT06447506 | Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. | TERMINATED | PHASE2 |
| NCT06881251 | A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06407934 | A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06526182 | A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis | ACTIVE_NOT_RECRUITING | — |
| NCT05492578 | Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials | ENROLLING_BY_INVITATION | PHASE2/PHASE3 |
| NCT04599946 | Goat Infant Formula Feeding and Eczema (the GIraFFE Study) | ACTIVE_NOT_RECRUITING | NA |
| NCT05999799 | A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis | TERMINATED | PHASE2 |